Lumera is a name used by several independent organizations operating in distinct industries, including life and pensions software, healthcare IT using blockchain and AI, finance-focused AI application tooling, and a regenerative medicine clinic; the name also appears on a public cryptocurrency listing. To avoid conflation, this article disambiguates the main entities known as “Lumera,” summarizing each based on their own public materials and noting where claims are vendor assertions that lack independent verification. [1] [2] [3]
Lumera AB operates in the Life & Pensions sector, providing software and consulting services designed to support customer-first transformations at pension providers, with an emphasis on an API‑first architecture, data-driven modernization, and a measured approach to AI summarized by the firm as the “Prudent Revolution.” The company highlights more than twenty years of experience in the domain, primarily serving Nordic and UK organizations. Its services include a SaaS administration platform covering multiple scheme types, migration of legacy systems via phased programs, and independent data consultancy aimed at turning policy and customer data into operational value. The corporate site also emphasizes security and risk management practices, and encourages prospective clients to “Start empowering your customers,” a line used alongside “Begin the Prudent Revolution” in its marketing copy. [1]
The company’s public newsroom includes dated developments. On 18 December 2025 it announced an agreement to acquire Acuity, a UK consultancy focused on public sector pensions. On 29 April 2026 it reported new board appointments: Johan Sidenmark, identified as former CEO of AMF, and Helena Holmgren, indicated as a finance lead at Monterro. The site references work across well-known Nordic and UK pension brands—examples include AMF, Movestic, Nordea, Nordnet, PP Pension, Skandia, SPP, Swedbank and Folksam—alongside casework on policy administration migrations, test automation, and consolidations. Copyright notices demonstrate active publishing in 2026. While the site positions Lumera AB as a registered trademark holder and outlines its client journey (migrate, extract value from data, enable new experiences via APIs), it does not on these pages supply a precise founding date, a headquarters address, comprehensive leadership biographies, or financials; such details would typically require consulting corporate filings or independent coverage. [1]
LumeraHealth presents “Lumera” as a healthcare IT platform built to unify patient and provider access to medical records and to reduce the administrative and workflow burden in clinical settings. The materials describe an “identity‑verified ecosystem” with real‑time identity proofing; an on‑chain access logging and verification mechanism branded TRACE Engine; and a patient‑facing app branded Lock by Lumera. The platform is said to run on the LUR Protocol, described as a private blockchain with a hybrid Proof‑of‑Authority/Proof‑of‑Stake consensus approach, and references LumaNodes as network or trust‑layer infrastructure components. A token styled $LUR is described as the native utility used within the network. The site states privacy‑first AI is layered in to summarize clinical documents, flag risks, and assist decision‑making, with the TRACE Engine recording auditable, timestamped actions on‑chain. Phrases presented prominently include “identity‑verified ecosystem,” “auditable, on‑chain access logs via the TRACE Engine,” and a tagline that reads, “Because in 2025 healthcare shouldn’t still feel like it’s stuck in 1995.” These items are vendor statements and should be treated as such unless corroborated by third‑party documentation. [4]
The token is positioned as a utility rather than a speculative asset, with stated roles that include securing the network under its consensus model, powering node participation and trust layers, enabling subscription discounts reportedly in the 10–30% range, and unlocking “programmable” features such as on‑chain clinical trials, gamified behaviors, and medical tokenization. Additional claims include a private network throughput above 2,000 TPS; a “green-friendly” energy posture based on the stated consensus approach; and “post‑quantum security” as part of the security posture. Regulatory and compliance references include HIPAA, GDPR, and ISO, and the site positions the platform as delivering immutable, auditable access logs. Performance-impact figures cited in marketing include “up to 50% increase in workflow,” “10+ hours/week reclaimed per clinician,” and a “67% drop in admin workload,” as well as a contextual problem statement that administrative waste accounts for hundreds of billions of dollars annually in healthcare. The site content reviewed does not supply independent verification, named client deployments, or third‑party audits alongside these claims, nor does it include founding date, founders’ names, or token supply/contract details; those items would require additional primary or independent sources to verify. [4]
LumeraPlatform, presented on lumerahq.com, markets a system that allows finance teams—controllers, accountants, and operations specialists—to “build apps and agents to put AI to work for Finance,” generating production-ready applications and AI agents from plain‑English workflow descriptions. The platform emphasizes enterprise governance out of the box: SOX‑grade audit trails, segregation of duties, change management, role‑based access control (RBAC), and single sign‑on (SSO), coupled with agent observability that exposes what agents did, why they did it, and what data they accessed. It positions human‑in‑the‑loop review as a core design choice (“nothing is posted without the human review workflows you define”), and describes comprehensive logging and timestamping of agent actions with exportable records. The site states deployments are hosted on AWS-managed infrastructure, and it includes an explicit data policy stating customer data is never used for model training (“Never. We do not do any model training.”). The page copy also asserts, “From the finance team that scaled OpenAI,” a claim that would require independent corroboration through biographies or press coverage before being repeated as a verified fact in external references. [2]
Representative use cases include month‑end close (automated reconciliation and evidence gathering, trial balance pulls, variance flagging), shared AP/AR mailboxes (agent triage and invoice data extraction with approval flows), vendor onboarding portals (document intake, AI validation, risk flagging, and approval routing), invoice processing (line‑item extraction, three‑way match checks, discrepancy flagging, draft journal entries), flux and variance analysis (ERP connectors to compare actuals versus budgets with drafted commentary), and contract review triggered by deals in CRM systems. Connectors cited include NetSuite, Stripe, Salesforce, QuickBooks, Xero, Google Sheets, Slack, and HubSpot, with marketing copy indicating that teams can “ship a first app in minutes” by describing workflows in natural language rather than initiating lengthy implementation projects. The site’s CTAs encourage sign‑ups and demos and present content sections for enterprises, accounting firms, and builders, but it does not list founders, a founding date, funding, or comprehensive technical architecture details on these pages. [2]
Lumera Regenerative Medicine operates a clinic with a published address at 6464 SW Borland Rd., Suite C3, Tualatin, Oregon 97062, United States, and a main phone line at +1 (503) 852‑9680. The clinic promotes online booking and contact via a site form, includes SMS messaging consent language, and offers digital gift certificates in denominations ranging from $500 to $1,000 with a one‑year validity period from purchase. The shop portal displays featured retail skincare brands, including Alastin, Skinbetter Science, and ZO Skin Health, and references social media presence on Instagram, Facebook, LinkedIn, and Threads. Legal language on the site states that content is for educational purposes only, that outcomes vary and are not guaranteed, that the site is protected by reCAPTCHA (subject to Google’s Privacy Policy and Terms of Service), and that users can unsubscribe from texts by replying STOP. The site indicates current operation with a 2026 copyright notice. [5]
The clinic advertises a broad menu of aesthetic and regenerative treatments. Categories listed on the shop and linked pages include Health & Wellness (e.g., bioidentical hormone replacement therapy, pelvic and sexual health offerings such as O‑Shot/P‑Shot and Emsella), Stem Cell Therapy, multiple facial treatment modalities (such as EmFace, microneedling, chemical peels, Hydrafacial, acne treatments), injectables (Botox/Dysport, dermal fillers, NovaThreads, Radiesse, Sculptra), laser and light‑based therapies (e.g., Bare HR laser hair removal, BBL Hero, ClearSilk, HALO, Moxi, SkinTyte), and body-focused treatments (CoolSculpting, EmSculpt, EmTone, PRP hair restoration). Statements on financing (“pay over time,” “no hard credit checks,” “0% APR options”) appear in the marketing language, but specific financing partners or terms are not identified on these pages and would require verification before being presented as confirmed facts. The site does not, on the captured pages, enumerate clinician names, licenses, board certifications, facility accreditations, or protocol/regulatory details related to its advertised stem cell therapy; any such details would need to be sourced from regulatory records or independently published documentation. [5]
A token entry with the name “Lumera” is present on CoinGecko. The listing is referenced here for disambiguation only; this article does not reproduce market data (price, market capitalization, supply, contract address, or chain) and does not assert any relationship between that listing and the vendor-described $LUR token referenced by LumeraHealth. Readers seeking pricing, supply, and contract details should consult the live CoinGecko page. [3]
The entities summarized in this article share a common name but appear—based on their respective websites—to be distinct in purpose, sector, and claimed offerings:
The materials cited come from each organization’s own site or the market listing page. Where claims relate to performance, compliance, security posture, or market adoption, the text above identifies them as vendor statements. Independent verification—e.g., regulatory certifications, third‑party security audits, clinical study results, named customer references, or corporate filings—would be needed to establish them as confirmed facts beyond marketing assertions. [4] [2]
No direct corporate relationship is established between Lumera AB, LumeraHealth’s initiative, LumeraPlatform (Lumera HQ), the clinic in Tualatin, or the token listing. Absent explicit disclosures tying these entities together, they should be treated as separate organizations that happen to share a name. Each subsection above is scoped to information found on the corresponding site or listing page and does not imply affiliation. [1] [4] [2] [5] [3]